Trends in antibiotic resistance of corneal pathogens: Part II. An analysis of leading bacterial keratitis isolates

Indian Journal of Ophthalmology

Volumn 47, Issue 2, 1999, Pages 101-109

  Sharma, Savitri ^a   Kunimoto, Derek Y ^b   Nagaraja Rao, T ^c   Garg, Prashant ^a   Rao, Gullapalli N ^a  

^a L V PRASAD EYE INSTITUTE   (India)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

Antibiotic resistance; Antibiotic sensitivity; Bacteria; Infectious keratitis; Treatment

Indexed keywords

EID: 23944477218     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology 1981;88:814-20.
2. Burd EM, Ogawa GSH, Hyndiuk RA. Bacterial keratitis and conjunctivitis. In: Smolin G, Thoft RA, editors. The Cornea. Scientific Foundations and Clinical Practice. 3rd ed. Boston: Little, Brown, & Co; 1994. p 115-67.
3. Asbell P, Stenson S. Ulcerative keratitis: Survey of 30 years' laboratory experience. Arch Ophthalmol 1982;100:77-80.
4. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980;90:38-47.
5. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE. Epidemiology of microbial keratitis in Southern California. A multivariate analysis. Ophthalmology 1987;94:1322-33.
6. McClellan KA, Bernard BJ, Billson FA. Microbial investigations in keratitis at the Sydney Eye Hospital. Aust NZ J Ophthalmol 1989;17:413-36.
7. Ormerod LD. Causation and management of microbial keratitis in subtropical Africa. Ophthalmology 1987;94:1662-68.
8. Neumann M, Sjostrand J. Central microbial keratitis in a Swedish city population. A three-year prospective study in Gothenburg. Acta Ophthalmol Copenh 1993;71:160-64.
9. Wahl JC, Katz HR, Abrams DA. Infectious keratitis in Baltimore. Ann Ophthalmol 1991;23:234-47.
10. Gonawardena SA, Ranasinghe KP, Arseculratne SN, Seimon CR, Ajello L. Survey of mycotic and bacterial keratitis in Sri Lanka. Mycopathologia 1994;127: 77-81.
11. Williams G, McClellan K, Billson F. Suppurative keratitis in rural Bangladesh: the value of gram stain in planning management. Int Ophthalmol 1991;15:131-35.
12. Sharma S, Kunimoto DY, Garg P, Rao GN. Trends in antibiotic resistance of corneal pathogens: Part I. An analysis of commonly used ocular antibiotics. Indian J Ophthalmol 1999;47:95-100.
13. Jones DB, Liesegang TJ, Robinson NM. Laboratory Diagnosis of Ocular Infections. Washington DC: Cumitech 13, American Society for Microbiology; 1981.
14. Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE, et al. Susceptibility of corneal and conjunctival pathogens to Ciprofloxacin. Cornea 1996;15:66-71.
15. Bower KS, Kowalski MS, Gordon YJ. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996;121:712-15.
16. Snyder ME, Katz HR. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992;114:336-38.
17. Maffett M, O'Day DM. Ciprofloxacin-resistant bacterial keratitis [letter]. Am J Ophthalmol 1993;115:545-46.
18. Koguchi M, Suzuki Y, Tanaka S, Fukayama S, Ishihara R, Deguchi K, et al. Antimicrobial activities of norfloxacin against clinical isolates from ocular infections. Jpn J Antibiot 1995;48:1009-25.
19. Mathers WD, Lemp MA. Corneal rim cultures. Cornea 1987;6:231-33.
20. Ooishi M, Miyao M. Antibiotic sensitivity of recent clinical isolates from patients with ocular infections. Ophthalmologica 1997;211:15S-24S.
21. Lindquist TD, Weber K, Spika J, Facklam R. Gentamicin-resistant streptococcal endophthalmitis after keratoplasty. Cornea 1990;9:88-89.
22. Gopinathan U, Agrawal V, Sharma S, Rao GN. Donor corneoscleral rim contamination by gentamicin-resistant organisms. Indian J Ophthalmol 1994;42:71-74.
23. Brown SF, Bloomfield SE, Tarn WI. The cornea destroying enzyme of Pseudomonas aeruginosa. Invest Ophthalmol 1974;13:174-80.
24. Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. Invest Ophthalmol Vis Sci 1990;31:1940-44.
25. Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Invest Ophthalmol Vis Sci 1990;31:2241-43.
26. Leibowitz, HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;12:34S-47S.
27. Hyundiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmol 1996;103:1854-62.
28. O'Brien TP, Maguire MG, Fink NE, Alfonso E, M Donnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol 1995;113:1257-65.
29. Neu HC. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991;112:15S-24S.
30. Vajpayee RB, Gupta SK, Angra SK, Munjal A. Topical norfloxacin therapy in Pseudomonas corneal ulceration. Cornea 1991;10:268-71.
31. Murphy PG, Ferguson WP. Corynebacterium jeikeium (Group JK) resistance to ciprofloxacin emerging during therapy [letter]. J Antimicrob Chemother 1987;20: 922-23.
32. Tauch A, Kassing F, Kalinowski J, Puhler A. The erythromycin resistance gene of the Corynebacterium xerosis R-plasmid pTP10 also carrying chloramphenicol, kanamycin, and tetracycline resistances is capable of transposition in Corynebacterium glutamicum. Plasmid 1995;33:168-79.
33. Roberts MC, Leonard RB, Briselden A, Schoenknecht FD, Coyle MB. Characterization of antibiotic-resistant Corynebacterium striatum strains. J Antimicrob Chemother 1992;30:463-74.
34. Ahmed K, Kawakarni K, Watanabe K, Mitsushima H, Nagatake T, Matsumoto K. Corynebacterium pseudodiphtheriticum: A respiratory tract pathogen. Clin Infect Dis 1995;20:41-46.
35. Williams DY, Selepak ST, Gill VJ. Identification of clinical isolates of nondiphtherial Corynebacterium species and their antibiotic susceptibility patterns. Diagn Microbiol Infect Dis 1993;17:23-28.
36. Matsuo K, Uete T. Evaluation of in-vitro antimicrobial activity of ccefazolin alone and in combination with cefmetazole or flomexef using agar dilution method and disk diffusion method. Jpn J Antibiot 1992;45:1253-66.
37. Torres Garcia M, Tejodor Junco MT, Gonzalez Martin M, Gonzalez Lama Z. Selection of subpopulations resistant to amikacin and netilmicin of gentamicin-resistant clinical strains of Staphylococcus aureus and Staphylococcus epidermidis. Zentralbl Bakteriol 1996;284:58-66.
38. Mader TH, Maher KL, Stulting RD. Gentamicin resistance in Staphylococcal corneal ulcers. Cornea 1991;10:408-10.
39. Callegan MC, Hill JM, Insler MS, Hobden JA, O' Callaghan RJ. Methiciliin-resistant Staphylococcus aureus keratitis in the rabbit: Therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res 1992;11:1111-19.
40. Utili R, Tripodi MF, Rosaria P, Andreana A, Locateli A, Rambaldi A, et al. Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin. New Microbiol 1996;9:309-14.
41. Hwang DG, Nakamura T, Trousdale MD, Smith TM. Combination antibiotic supplementation of corneal storage medium. Am J Ophthalmol 1993;115:299-308.
42. Burnie JP, Loudon KW. Ciprofloxacin-resistant Staphylococcus epidermidis and hands [letter]. Lancet 1997;349:649.
43. Schwarz S, Gregory PD, Werckenthin C, Curnockc S, Dyke KG. A novel plasmid from Staphylococcus epidermidis specifying resistance to kanamycin, neomycin and tetracycline. J Med Microbiol 1996;45:57-63.
44. Perichon B, Tankovic J, Courvalin P. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997;41:1166-67.
45. Renneberg J, Niemann LL, Gutschik E. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J Antimicrob Chemother 1997;39:135-40.
46. Gratten M, Nimmo G, Carlisle J, Shoonneveldt J, Seneviratue E, Kelly R, et al. Emergence of further serotypes of multiple drug-resistant Streptococcus pneumonia in Queensland. Commun Dis Intell 1997;21:133-36.
47. Wise R, Brenwald N, Gill M, Fraise M. Streptococcus pneumoniae resistance to fluoroquinolones [letter]. Lancet 1996;348:1660.
48. Skull SA, Leach AJ, Currie BJ. Streptococcus pneumoniae carriage and penicillin/ceftriaxone resistance in hospitalized children in Darwin. Aust NZ J Med 1996;26:391-95.
49. Schutze GE, Lewno MJ, Mason EO Jr. Use of ceftizoxime screening for the detection of cephalosporin-resistant pneumococci. Diagn Microbiol Infect Dis 1997;27:99-101.
50. Ormerod LD, Heseltine PNR, Alfonso E, Becker MI, Kenyon KR, Baerveldt G, et al. Gentamicin-resistant pseudomonal infection: Rationale for a redefinition of ophthalmic antimicrobial sensitivities. Cornea 1989;8:195-99.